(Q45052309)

8 December 2017

title

Iron-dependent hydroxyl radical formation and DNA damage from a novel metabolite of the clinically active antitumor drug VP-16. (English)

1 reference

8 December 2017

Sinha BK

1

1 reference

8 December 2017

Eliot HM

series ordinal

2

1 reference

8 December 2017

Kalayanaraman B

series ordinal

3

1 reference

8 December 2017

language of work or name

English

0 references

publication date

1 January 1988

1 reference

8 December 2017

1 reference

8 December 2017

volume

227

1 reference

8 December 2017

issue

2

1 reference

8 December 2017

page(s)

240-244

1 reference

Effect of VP-16-213 on the intracellular degradation of DNA in HeLa cells

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2888%2980906-2

Inhibition of epipodophyllotoxin cytotoxicity by interference with topoisomerase-mediated DNA cleavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2888%2980906-2

In vitro metabolism of etoposide (VP-16-213) by liver microsomes and irreversible binding of reactive intermediates to microsomal proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2888%2980906-2

Oxidative destruction of DNA by the adriamycin-iron complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2888%2980906-2

Monoclonal antibody to transferrin receptor blocks transferrin binding and inhibits human tumor cell growth in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2888%2980906-2

Comparison of cytotoxicity and DNA breakage activity of congeners of podophyllotoxin including VP16-213 and VM26: a quantitative structure-activity relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2888%2980906-2

Free radical metabolism of VP-16 and inhibition of anthracycline-induced lipid peroxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2888%2980906-2

Irreversible binding of etoposide (VP-16-213) to deoxyribonucleic acid and proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2888%2980906-2

Microsomal interactions and inhibition of lipid peroxidation by etoposide (VP-16, 213): implications for mode of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2888%2980906-2

Peroxidative free radical formation and O-demethylation of etoposide(VP-16) and teniposide(VM-26)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2888%2980906-2

Free radical metabolism of hydralazine. Binding and degradation of nucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2888%2980906-2

Doxorubicin-dependent lipid peroxidation at low partial pressures of O2

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2888%2980906-2

Hydroxyl free radical formation from hydrogen peroxide by ferrous iron-nucleotide complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2888%2980906-2

How can iron salts mediate the degradation of nucleos(t)ides by elliptinium acetate via free-radicals?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2888%2980906-2

Release of iron from ferritin by cardiotoxic anthracycline antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2888%2980906-2

10.1016/0014-5793(88)80906-2

21 January 2018

Identifiers

DOI

1 reference

8 December 2017

1 reference